Shanghai Hengrui Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 2001-12-04
- Employees
- -
- Market Cap
- -
- Website
- http://www.shhrp.com
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 156
- Registration Number
- NCT06474455
- Locations
- 🇨🇳
HeNan CANCER HOSPITAL, Zhenzhou, Henan, China
🇨🇳Zhejiang Cancer Hospital, Zhejiang, HangZhou, China
Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 88
- Registration Number
- NCT06439589
- Locations
- 🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳Shanghai Chest Hospital, Shanghai, Shanghai, China
The Trial of SHR6508 in Secondary Hyperparathyroidism
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 486
- Registration Number
- NCT06434961
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT06417554
SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 924
- Registration Number
- NCT06350006
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 303
- Registration Number
- NCT06236295
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT06199037
- Locations
- 🇨🇳
The First Affiliated hospital of USTC, Hefei, Anhui, China
A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 170
- Registration Number
- NCT06108492
- Locations
- 🇨🇳
Fudan University Zhongshan Hospital, Shanghai, Shanghai, China
A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 132
- Registration Number
- NCT06104553
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT06012812
- Locations
- 🇨🇳
Huashan Hospital,Fudan University, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath